Pranoti Gangurde

Statistics

Publications

Citations

1.4K

H-Index

Active since

2004

Affiliations

Millennium Engineering and Integration (United States)(Current)

La Roche College

Aileron (United States)

Pranoti Gangurde is an author at Millennium Engineering and Integration (United States) specializing in medicine, pharmacology, and molecular oncology.

Publications per year

2004–2023

Publications

Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Yong S. Chang, Bradford Graves, Vincent Guerlavais et al. · Proceedings of the National Academy of Sciences · 2013 · 661 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development

Vincent Guerlavais, Tomi K. Sawyer, Luis A. Carvajal et al. · Journal of Medicinal Chemistry · 2023 · 125 citations · Full text

Medicine, Oncology, Pharmacology +14

A Selective Small Molecule IκB Kinase β Inhibitor Blocks Nuclear Factor κB-Mediated Inflammatory Responses in Human Fibroblast-Like Synoviocytes, Chondrocytes, and Mast Cells

Danyi Wen, Yuhua Nong, Jennifer G. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 113 citations

Medicine, Medicinal Chemistry, Pharmacology +17

IKKβ inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis

Lisa Schopf, Anneli Savinainen, Karen S. Anderson et al. · Arthritis & Rheumatism · 2006 · 80 citations

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 6